Atlas Trials

Phase II Dose-ranging Study of APD421 in PONV

Clinical trial NCT01510704 · COMPLETED

Trial details

NCT number
NCT01510704
Sponsor
Acacia Pharma Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Postoperative Nausea and Vomiting
Start date
2012-01-01
Primary completion
2012-04-01
Enrollment
215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.